What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to formally announce and provide investors with access to Gilead Sciences' financial results for the third quarter and the first nine months of 2012, which were detailed in a press release issued on October 23, 2012.

Where can I find the actual financial numbers for the quarter?

The detailed financial results, including revenue, earnings, and other performance metrics for the quarter ended September 30, 2012, are located in the press release filed as Exhibit 99.1 to this 8-K filing.

What is the significance of the company presenting both GAAP and non-GAAP financial information?

Gilead presents both GAAP and non-GAAP financial information because management uses the non-GAAP figures internally for operating, budgeting, and financial planning. They believe this non-GAAP data offers useful supplemental information to investors, providing additional context beyond the standard GAAP reporting. A reconciliation between the two is available in the press release.

What does it mean that the information is 'furnished' and not 'filed'?

The filing states that the information in the 8-K and its exhibit is furnished, not 'filed,' under Section 18 of the Securities Exchange Act of 1934. This generally means the company assumes less liability for the accuracy of this specific disclosed information compared to information that is formally 'filed.' It also means it's not automatically incorporated into other SEC filings unless explicitly stated.

GILD 8-K: Earnings & Results

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on October 23, 2012, announcing its financial results for the third quarter and the first nine months of 2012, ended September 30, 2012. The report primarily directs investors to a press release (Exhibit 99.1) containing both GAAP and non-GAAP financial information for the relevant periods, comparing them to 2011 results. Management finds the non-GAAP figures useful for internal operational planning and believes they offer supplemental insight to investors when viewed alongside GAAP statements. A reconciliation of GAAP to non-GAAP measures is available within the press release. While this 8-K filing itself does not contain the detailed financial figures, its purpose is to formally announce and provide access to the press release that does. Investors should review Exhibit 99.1 for specific revenue, earnings, and other financial performance metrics. The company emphasizes that the information presented in this 8-K and its exhibit is not considered 'filed' for certain regulatory purposes, meaning it doesn't carry the same liabilities as a formally filed financial statement under Section 18 of the Exchange Act, nor is it automatically incorporated by reference into other SEC filings.

Key Highlights

1Gilead Sciences announced third quarter and nine-month 2012 financial results via an 8-K filing on October 23, 2012.
2The primary disclosure is a press release (Exhibit 99.1) containing detailed financial results and comparisons to 2011.
3Both GAAP and non-GAAP financial measures are presented, with management highlighting the utility of non-GAAP data for internal planning and investor insight.
4Investors are directed to the press release for specific financial performance figures, including revenue and earnings.
5A reconciliation between GAAP and non-GAAP financial information is provided within the press release.
6The filing specifies that the information is furnished and not 'filed' under Section 18 of the Exchange Act, impacting liability and incorporation by reference.
7The press release was issued on October 23, 2012, following the quarter end of September 30, 2012.

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 23, 2012)

Summary

Key Highlights

Frequently Asked Questions